168 related articles for article (PubMed ID: 32924403)
1. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
[TBL] [Abstract][Full Text] [Related]
2. Psoriasiform eruption associated with graft-versus-host disease.
Taguchi S; Kawachi Y; Fujisawa Y; Nakamura Y; Furuta J; Otsuka F
Cutis; 2013 Sep; 92(3):151-3. PubMed ID: 24153145
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
5. Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey.
Ilhan O; Akan H; Koç H; Gürman G; Arslan O; Ozcan M; Erdi H; Erdem C; Konuk N; Uysal A; Beksaç M
Hematol Cell Ther; 1997 Jun; 39(3):133-6. PubMed ID: 9262989
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
[TBL] [Abstract][Full Text] [Related]
7. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
8. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Soiffer RJ; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman RL; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
Blood; 1997 Apr; 89(8):3039-47. PubMed ID: 9108425
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation.
Favre A; Cerri A; Bacigalupo A; Lanino E; Berti E; Grossi CE
Am J Surg Pathol; 1997 Jan; 21(1):23-34. PubMed ID: 8990138
[TBL] [Abstract][Full Text] [Related]
10. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
11. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease.
Kohler S; Hendrickson MR; Chao NJ; Smoller BR
Am J Surg Pathol; 1997 Sep; 21(9):988-96. PubMed ID: 9298874
[TBL] [Abstract][Full Text] [Related]
12. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
13. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
[TBL] [Abstract][Full Text] [Related]
14. Review of Graft-Versus-Host Disease.
Ramachandran V; Kolli SS; Strowd LC
Dermatol Clin; 2019 Oct; 37(4):569-582. PubMed ID: 31466596
[TBL] [Abstract][Full Text] [Related]
15. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
16. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
17. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).
Socié G; Cahn JY; Carmelo J; Vernant JP; Jouet JP; Ifrah N; Milpied N; Michallet M; Lioure B; Pico JL; Witz F; Molina L; Fischer A; Bardou VJ; Gluckman E; Reiffers J
Br J Haematol; 1997 Jun; 97(4):865-70. PubMed ID: 9217190
[TBL] [Abstract][Full Text] [Related]
18. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
19. Graft-vs.-host disease.
Woo SB; Lee SJ; Schubert MM
Crit Rev Oral Biol Med; 1997; 8(2):201-16. PubMed ID: 9167093
[TBL] [Abstract][Full Text] [Related]
20. A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation.
Tanaka K; Sullivan KM; Shulman HM; Sale GE; Tanaka A
J Dermatol; 1991 Jan; 18(1):11-7. PubMed ID: 2050901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
